SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921530-00-000034
Filing Date
2000-02-14
Accepted
2000-02-14 00:00:00
Documents
1
Group Members
DUQUESNE CAPITAL MANAGEMENT, L.L.C.GEORGE SOROSQIH MANAGEMENT INVESTOR, L.P.QIH MANAGEMENT, INC.QUANTUM INDUSTRIAL PARTNERS LDCSOROS FUND MANAGEMENT LLCSTANLEY F. DRUCKENMILLER

Document Format Files

Seq Description Document Type Size
1 ADMT #2 TO SC 13G RE TRIANGLE PHARMACEUTICALS,INC. SC 13G/A 29023
  Complete submission text file 0000921530-00-000034.txt   31374
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

IRS No.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47359 | Film No.: 537411
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKIN, GUMP, STRAUSS,HAUER,FELD, 399 PARK AVENUE NEW YORK NY 10022
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 2128721054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

IRS No.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231